Data as of Jan 30
| -0.36 / -4.83%|
The 5 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +97.46% increase from the last price of 7.09.
The current consensus among 5 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.